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In eukaryotic cells, protein disulfide bond formation occurs in 
the lumen of the ER as part of the folding and assembly process 
for newly synthesized secretory proteins. A pathway formed by 
the oxidoreductases ERO1 (ER oxidoreductin 1) and protein   
disulfide isomerase (PDI) drives the thiol–disulfide equilibrium 
in the ER toward disulfide bond formation (Tu and Weissman, 
2004; Sevier and Kaiser, 2008). PDI directly catalyzes the for-
mation of disulfides in secretory proteins, accepting electrons 
from thiols in folding nascent chains. To sustain additional rounds 
of protein disulfide formation, PDI transfers these electrons to 
ERO1. In turn, ERO1 passes its electrons to molecular oxygen 
and/or alternate acceptors in the cell.
Despite an overall conservation of the ERO1–PDI pathway 
among eukaryotes, important differences exist between organisms. 
Although many simple eukaryotes like Saccharomyces cerevisiae 
and Caenorhabditis elegans encode a single ERO1, mammals con-
tain two ERO1 isoforms, ERO1- and -. At present, no major 
differences in redox activities or substrate interactions have been 
identified between the characterized human paralogues. Continu-
ing this trend, in this issue, Zito et al. show that the two mouse 
ERO1 proteins have similar in vitro biochemical activities. Dis-
tinct tissue distribution and transcriptional regulation for the ERO1   
isoforms has suggested the potential for unique contributions   
toward disulfide bond formation in the cell (Pagani et al., 2000; 
Dias-Gunasekara et al., 2005). However, the actual redundancy 
and/or specificity for the ERO1 isoforms in vivo has remained 
an open question. Zito et al. (2010) begin to address this issue by   
focusing on the roles of ERO1- and - in mice. Their experiments 
suggest a selective, nonredundant function for ERO1- in oxidative 
protein folding in insulin-producing cells. Their work also provides 
the first indication as to how ERO1 activity impacts the develop-
ment of individual tissues, advancing our knowledge of the role   
for ERO1 in oxidative folding in the animal.
The  oxidoreductase  ERO1  (endoplasmic  reticulum  [ER] 
oxidoreductin 1) is thought to be crucial for disulfide bond 
formation in the ER. In this issue, Zito et al. (2010. J. Cell 
Biol. doi:10.1083/jcb.200911086) examine the division 
of labor between the two mammalian isoforms of ERO1 
(ERO1- and -) in oxidative folding. Their analysis reveals 
a selective role for ERO1- in insulin production and a 
surprisingly minor contribution for either ERO1 isoform 
on immunoglobulin folding and secretion.
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The work of Zito et al. (2010) primarily focuses on ERO1-, 
which has been the lesser characterized of the two isoforms. Using 
antisera specific for each of the mouse ERO1 isoforms, they   
observe tissue-specific expression of the mouse isoforms similar to 
that previously reported for the human ERO1s (Pagani et al., 2000; 
Dias-Gunasekara et al., 2005). Most striking was a strong and   
selective staining for ERO1- in the pancreas. In contrast, ERO1- 
was detected in all tissues. To study the cellular activity of ERO1-, 
Zito et al. (2010) developed a mouse model homozygous for an in-
sertion in intron 14 of the Ero1lb locus that compromised ERO1- 
expression in the pancreas. Disruption of ERO1- resulted in   
defective oxidative folding in the ER; in particular, homozygous 
mutant mice showed a kinetic delay in the processing of disulfide-
bonded proinsulin to insulin. As might have been anticipated by 
this delay in the folding of disulfide-linked insulin, loss of ERO1- 
function adversely impacted insulin biogenesis and glycemic con-
trol in mice. By 3 mo of age, the majority of homozygous mutant 
mice showed a stable diabetic phenotype.
A surprise came upon further characterization of the resid-
ual oxidative folding observed in the homozygous ERO1- 
mutant, which might have been expected to be a product of the 
activity from the remaining ERO1 isoform. Remarkably, the 
residual disulfide-linked folding of insulin does not depend on 
ERO1-; no enhancement in phenotype was observed with con-
comitant disruption of both the Ero1l and Ero1lb loci. Considering 
that the ERO1 genes in both S. cerevisiae and C. elegans are es-
sential for viability, the viability of the mutant mouse lacking 
both isoforms of ERO1 is quite surprising. These observations 
suggest that ERO1- serves as an islet-selective isoform of ERO1 
that enhances the oxidative folding capacity of insulin-producing 
cells. At least in the pancreas, the two ERO1 isoforms appear 
nonredundant. An additional unexpected result came with the 
analysis of the oxidative folding for immunoglobulin-producing 
cells in the double mutant mouse that revealed only a modest 
delay in the oxidative folding of IgM. As the authors propose, 
this provides strong evidence for an important ERO1-independent 
mechanism for generating disulfide bonds in mammals. What 
accounts for the residual activity remains an open question.
Only three classes of enzymes that can couple small mol-
ecule redox chemistry to the de novo formation of disulfides have 
been identified in the ER: ERO1, VKOR, and the ERV/QSOX 
superfamily. VKOR catalyzes the reduction of vitamin K, which 
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mutation was accentuated by genomic disruption of ERO1-  
expression. The authors put forth several distinctions between cul-
tured cells relative to tissues in the animal that may contribute to the 
differences observed in cell culture relative to the whole animal,   
including differences in oxygen levels and/or developmental pro-
grams. Alternatively, these disparities may relate to experimental 
differences: a stable disruption of ERO1- in the mouse (disrupted 
throughout development) relative to a transient RNAi knockdown 
in the cultured system. Importantly, elucidating the contributing 
factors toward the different phenotypic outcomes of the loss of 
ERO1 activity will be an important step toward understanding how 
redox imbalances are offset in the whole organism.
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is ultimately required for proper blood coagulation. It has been 
suggested that the catalytic cycle of VKOR is coupled with oxi-
dative folding in the ER via PDI (Wajih et al., 2007). The ERV/
QSOX superfamily consists of disulfide bond–forming catalysts 
that share a common flavin-binding domain that is found either 
alone (ERVs; Fass, 2008) or fused with a PDI-like domain (QSOX 
family; Thorpe and Kodali, 2010). Erv2 is the only ER-localized 
ERV protein and is a fungal-specific enzyme that can operate par-
allel to ERO1 in the yeast ER to introduce disulfide bonds into 
substrate proteins (Sevier et al., 2001). Erv2 is not present in mice. 
However, proteins of the QSOX family are present in vertebrates, 
plants, and protists. Mammalian QSOX enzymes were first char-
acterized as extracellular proteins; however, recently, QSOX iso-
forms have been localized to the ER/Golgi region (Tury et al., 
2004; Chakravarthi et al., 2007). It will be interesting to deter-
mine whether QSOX or VKOR enzymes account for the oxidiz-
ing power remaining in the ER of mammalian cells lacking ERO1 
(Fig. 1). Intriguingly, genetic data in flies suggest that a member 
of the QSOX family may contribute to disulfide bond formation 
when the function of the single Ero1l gene in the fly is compro-
mised (Tien et al., 2008). Future efforts in the field will surely 
focus on the further characterization of alternate (and perhaps 
novel) oxidase systems beyond ERO1 in the ER lumen and how 
these additional pathways relate to the ERO1–PDI pathway.
At a broader level, the work of Zito et al. (2010) also high-
lights the challenge in reconciling an understanding of redox ho-
meostasis in cultured cells with the additional complexities present 
in a whole animal. Alteration of ERO1 activity has been shown to 
help cells cope with redox imbalances in the ER of yeast and worms 
(Harding et al., 2003; Haynes et al., 2004; Marciniak et al., 2004). 
In keeping with these prior studies, Zito et al. (2010) observed that 
knockdown of ERO1- in cultured Min6 cells strongly protected 
cells from toxicity of an insulin mutant defective for oxidative fold-
ing (proinsulin
Akita). However, the benefits caused by a decrease in 
ERO1 activity in cultured cells were not observed in pancreatic 
cells of live mice; the diabetic phenotype of the proinsulin
Akita  
Figure 1.  Pathways for oxidative folding in the ER of Mus musculus. Mice 
contain two ERO1 isoforms ( and ) that use PDI and/or PDI-like proteins 
(PDI(s)) to oxidize substrates. ERO1- has a specific impact on the oxidative 
folding of insulin in the mouse pancreas (Zito et al., 2010). VKOR and QSOX 
proteins may also facilitate oxidative folding in the ER, although their connec-
tions to folding in the ER lumen are less well established. VKOR, QSOX, or 
alternative unidentified pathways in the ER, including small molecules, may 
allow for the oxidative folding of IgM in the absence of ERO1 activity.